Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03376035 · ClinicalTrials.gov registry record · NA

Pilot Study Assessing Breast Temperature in Breast Cancer Patients

A NA study of Breast Reconstruction, sponsored by Duke University.

Completed
Registry status
NA
Development phase
52
Enrollment target
1
Study location

NCT03376035 is a NA study of Breast Reconstruction that has completed, run by Duke University. The registered enrollment target is 52 participants, below the 391-participant average among 18 other Breast Reconstruction trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03376035, a NA study of Breast Reconstruction, has completed, sponsored by Duke University.

COMPLETED
Registry status
NA
Development phase
52 participants
Enrollment target
1
Study location

Study Summary

Our investigators plan to measure the skin on the breast six months after breast reconstruction. The non-reconstructed breast will be used as the control for subject with unilateral reconstruction only. For those who have BILATERAL reconstruction, a core temperature will be obtained from the ear.

Conditions Studied

Interventions

  • OTHER Temperature measurement of breast

Study Locations (1)

North Carolina

  • Duke University Medical Center - Durham

Trial Details

FieldValue
Enrollment Target 52 participants
Start Date 2017-12-05
Est. Completion 2019-01-07
Phase NA

Sponsor

Duke University

1,725 total trials

What the Registry Record Tells You About NCT03376035

The ClinicalTrials.gov registry entry for NCT03376035 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 52 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 391-participant average among 18 other Breast Reconstruction trials with a reported enrollment target (87% lower). The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Breast Reconstruction appearing as the primary indexed condition, and to 1 intervention - of which Temperature measurement of breast is the first listed.

NCT03376035 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.

Frequently Asked Questions

What is clinical trial NCT03376035 about?

NCT03376035 is a clinical study titled "Pilot Study Assessing Breast Temperature in Breast Cancer Patients". Our investigators plan to measure the skin on the breast six months after breast reconstruction. The non-reconstructed breast will be used as the control for subject with unilateral reconstruction only. For those who have BILATERAL reconstruction, a core temperature will be obtained from the ear.

What is the current status of trial NCT03376035?

This trial is currently completed. It is a NA study. The enrollment target is 52 participants. The study started on 2017-12-05. Estimated completion is 2019-01-07.

What conditions does trial NCT03376035 study?

This clinical trial studies the following conditions: Breast Reconstruction.

What interventions are being tested in trial NCT03376035?

The interventions under investigation include: Temperature measurement of breast (OTHER).

Who is sponsoring clinical trial NCT03376035?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03376035 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Breast Reconstruction

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.